{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T05:09:07Z","timestamp":1791263347509,"version":"4.1.0"},"reference-count":35,"publisher":"American Chemical Society (ACS)","issue":"14","license":[{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/pubs.acs.org\/page\/policy\/authorchoice_termsofuse.html"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56AI099476"],"award-info":[{"award-number":["R56AI099476"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tropical protozoal infections are a significant cause of morbidity and mortality worldwide; four in particular (human African trypanosomiasis (HAT), Chagas disease, cutaneous leishmaniasis, and malaria) have an estimated combined burden of over 87 million disability-adjusted life years. New drugs are needed for each of these diseases. Building on the previous identification of NEU-617 (1) as a potent and nontoxic inhibitor of proliferation for the HAT pathogen (Trypanosoma brucei), we have now tested this class of analogs against other protozoal species: T. cruzi (Chagas disease), Leishmania major (cutaneous leishmaniasis), and Plasmodium falciparum (malaria). Based on hits identified in this screening campaign, we describe the preparation of several replacements for the quinazoline scaffold and report these inhibitors\u2019 biological activities against these parasites. In doing this, we have identified several potent proliferation inhibitors for each pathogen, such as 4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)-6-(4-((4-methyl-1,4-diazepan-1-yl)sulfonyl)phenyl)quinoline-3-carbonitrile (NEU-924, 83) for T. cruzi and N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-7-(4-((4-methyl-1,4-diazepan-1-yl)sulfonyl)phenyl)cinnolin-4-amine (NEU-1017, 68) for L. major and P. falciparum.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.5b00515","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T15:06:51Z","timestamp":1434640011000},"page":"5522-5537","source":"Crossref","is-referenced-by-count":69,"title":["Protozoan Parasite\nGrowth Inhibitors Discovered by\nCross-Screening Yield Potent Scaffolds for Lead Discovery"],"prefix":"10.1021","volume":"58","author":[{"given":"William","family":"Devine","sequence":"first","affiliation":[{"name":"Northeastern University , , 360 Huntington Avenue , , ,","place":["Boston, Massachusetts, United States, 02115"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Woodring","sequence":"additional","affiliation":[{"name":"Northeastern University , , 360 Huntington Avenue , , ,","place":["Boston, Massachusetts, United States, 02115"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Swaminathan","sequence":"additional","affiliation":[{"name":"Northeastern University , , 360 Huntington Avenue , , ,","place":["Boston, Massachusetts, United States, 02115"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Amata","sequence":"additional","affiliation":[{"name":"Northeastern University , , 360 Huntington Avenue , , ,","place":["Boston, Massachusetts, United States, 02115"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Patel","sequence":"additional","affiliation":[{"name":"Northeastern University , , 360 Huntington Avenue , , ,","place":["Boston, Massachusetts, United States, 02115"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessey","family":"Erath","sequence":"additional","affiliation":[{"name":"New York University School of Medicine , , 341 E. 25th St. , , ,","place":["New York, New York, United States, 10010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma E.","family":"Roncal","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute for Research , , 2460 Linden Lane , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Lee","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute for Research , , 2460 Linden Lane , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Leed","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute for Research , , 2460 Linden Lane , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Rodriguez","sequence":"additional","affiliation":[{"name":"New York University School of Medicine , , 341 E. 25th St. , , ,","place":["New York, New York, United States, 10010"]},{"name":"New York University School of Medicine , , , ,","place":["New York, New York, United States, 10010"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kojo","family":"Mensa-Wilmot","sequence":"additional","affiliation":[{"name":"University of Georgia , , , ,","place":["Athens, Georgia, United States, 30602"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Sciotti","sequence":"additional","affiliation":[{"name":"Walter Reed Army Institute for Research , , 2460 Linden Lane , , ,","place":["Silver Spring, Maryland, United States, 20910"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Pollastri","sequence":"additional","affiliation":[{"name":"Northeastern University , , 360 Huntington Avenue , , ,","place":["Boston, Massachusetts, United States, 02115"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2015,6,18]]},"reference":[{"key":"2026090305340405800_cit1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases\nand injuries in 21 regions, 1990\u20132010: A systematic analysis\nfor the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"2026090305340405800_cit2","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4155\/fmc.11.92","article-title":"Target\nrepurposing for neglected diseases","volume":"3","author":"Pollastri","year":"2011","journal-title":"Future Med.\nChem."},{"key":"2026090305340405800_cit3","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ejmech.2012.07.038","article-title":"The human Aurora kinase inhibitor\ndanusertib is a lead compound for anti-trypanosomal drug discovery\nvia target repurposing","volume":"62","author":"Ochiana","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"2026090305340405800_cit4","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/jm500361r","article-title":"Establishment of a structure-activity\nrelationship of the NVP-BEZ235 chemotype as a lead for African sleeping\nsickness","volume":"57","author":"Seixas","year":"2014","journal-title":"J. Med. Chem."},{"key":"2026090305340405800_cit5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001297","article-title":"The susceptibility\nof trypanosomatid pathogens to PI3\/mTOR kinase inhibitors affords\na new opportunity for drug repurposing","volume":"5","author":"Diaz-Gonzalez","year":"2011","journal-title":"PLoS\nNeglected Trop. Dis."},{"key":"2026090305340405800_cit6","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1021\/jm400349k","article-title":"Kinase scaffold repurposing for neglected disease drug\ndiscovery: Discovery of an efficacious, lapatanib-derived lead compound\nfor trypanosomiasis","volume":"56","author":"Patel","year":"2013","journal-title":"J. Med. Chem."},{"key":"2026090305340405800_cit7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1039\/C4MD00045E","article-title":"Repurposing\nhuman Aurora kinase inhibitors as leads for anti-protozoan drug discovery","volume":"5","author":"Patel","year":"2014","journal-title":"MedChemComm"},{"key":"2026090305340405800_cit8","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1021\/jm201148s","article-title":"Pharmacological\nvalidation of Trypanosoma brucei phosphodiesterases\nB1 and B2 as druggable targets for African sleeping sickness","volume":"54","author":"Bland","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026090305340405800_cit9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056150","article-title":"Lapatinib-binding\nprotein kinases in the african trypanosome: identification of cellular\ntargets for kinase-directed chemical scaffolds","volume":"8","author":"Katiyar","year":"2013","journal-title":"PLoS One"},{"key":"2026090305340405800_cit10","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-6-127","article-title":"Comparative analysis\nof the kinomes of three pathogenic trypanosomatids: Leishmania major, Trypanosoma brucei and Trypanosoma cruzi","volume":"6","author":"Parsons","year":"2005","journal-title":"BMC Genomics"},{"key":"2026090305340405800_cit11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1039\/C4MD00441H","article-title":"Evaluation of aromatic 6-substituted thienopyrimidines\nas scaffolds against parasites that cause trypanosomiasis, leishmaniasis,\nand malaria","volume":"6","author":"Woodring","year":"2015","journal-title":"MedChemComm"},{"key":"2026090305340405800_cit12","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.0708281105","article-title":"6-Ethynylthieno[3,2-d]-\nand 6-ethynylthieno[2,3-d]pyrimidin-4-anilines as tunable covalent\nmodifiers of ErbB kinases","volume":"105","author":"Wood","year":"2008","journal-title":"Proc. Natl. Acad.\nSci. U.S.A."},{"key":"2026090305340405800_cit13","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.bmcl.2009.01.080","article-title":"Synthesis and evaluation\nof aniline headgroups for alkynyl thienopyrimidine dual EGFR\/ErbB-2\nkinase inhibitors","volume":"19","author":"Waterson","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026090305340405800_cit14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bmcl.2008.11.023","article-title":"Synthesis\nand stereochemical effects of pyrrolidinyl-acetylenic\nthieno[3,2-d]pyrimidines as EGFR and ErbB-2 inhibitors","volume":"19","author":"Stevens","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026090305340405800_cit15","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.1016\/j.bmcl.2008.09.090","article-title":"Dual EGFR\/ErbB-2 inhibitors from novel pyrrolidinyl-acetylenic\nthieno[3,2-d]pyrimidines","volume":"18","author":"Hubbard","year":"2008","journal-title":"Bioorg. Med. Chem.\nLett."},{"key":"2026090305340405800_cit16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF01317857","article-title":"Characterization\nof the size and charge heterogeneities of human\nleukocyte interferon populations","volume":"56","author":"Lin","year":"1978","journal-title":"Arch. Virol."},{"key":"2026090305340405800_cit17","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1021\/jo901833y","article-title":"Phenylalanine\naminomutase-catalyzed addition of ammonia to substituted cinnamic\nacids: a route to enantiopure alpha- and beta-amino acids","volume":"74","author":"Szymanski","year":"2009","journal-title":"J. Org. Chem."},{"key":"2026090305340405800_cit18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1021\/jo00262a047","article-title":"Preparation of highly substituted 2-pyridones by reaction\nof vinyl isocyanates and enamines","volume":"54","author":"Rigby","year":"1989","journal-title":"J. Org. Chem."},{"key":"2026090305340405800_cit19","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1021\/jm061066t","article-title":"Selective urokinase-type\nplasminogen activator inhibitors. 4. 1-(7-Sulfonamidoisoquinolinyl)guanidines","volume":"50","author":"Fish","year":"2007","journal-title":"J. Med. Chem."},{"key":"2026090305340405800_cit20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1039\/C4MD00441H","article-title":"Evaluation of aromatic 6-substituted thienopyrimidines\nas scaffolds against parasites that cause trypanosomiasis, leishmaniasis,\nand malaria","volume":"6","author":"Woodring","year":"2015","journal-title":"MedChemComm"},{"key":"2026090305340405800_cit21","unstructured":"Benish, M. A.; Lawless, M.; Budde, R. J. A.\n          Preparation\nof thienopyrimidine-based inhibitors of the Src tyrosine kinases family. WO2002057271A2, 2002."},{"key":"2026090305340405800_cit22","unstructured":"Buchmann, B.; Braeuer, N.; Koppitz, M.; Peters, O.; Ter Laak, A.; Lindenthal, B.; Langer, G.; Wintermantel, T.\n          Preparation of\nindolylethylthienopyrimidylamines as EP2 receptor modulators. WO2009007421A1, 2009."},{"key":"2026090305340405800_cit23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1747-0285.2010.00989.x","article-title":"1,4-Thienodiazepine-2,5-diones\nvia\nMCR (I): synthesis, virtual space and p53-Mdm2 activity","volume":"76","author":"Huang","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"2026090305340405800_cit24","unstructured":"Aicher, T. D.; Boyd, S. A.; Chicarelli, M. J.; Condroski, K. R.; Hinklin, R. J.; Singh, A.\n          2-Aminopyridine\nderivatives as glucokinase activators and their preparation, pharmaceutical\ncompositions and use in the treatment of diseases. WO2008118718A2, 2008."},{"key":"2026090305340405800_cit25","unstructured":"Caferro, T. R.; Chamberlain, S. D.; Donaldson, K. H.; Harris, P. A.; Gaul, M. D.; Uehling, D. E.; Vanderwall, D. E.\n          Preparation\nof alkynyl thienopyrimidines as protein tyrosine kinase inhibitors\nuseful against cancer and other disorders. WO2003053446A1, 2003."},{"key":"2026090305340405800_cit26","unstructured":"Engelhardt, H.; Kofink, C.; McConnell, D.\n          Preparation\nof heterocyclic carboxylic acid amides as PDK1 inhibitors. WO2011131741A1, 2011."},{"key":"2026090305340405800_cit27","doi-asserted-by":"crossref","first-page":"6368","DOI":"10.1021\/jm100394y","article-title":"Discovery\nof a potent, selective, and orally bioavailable\npyridinyl-pyrimidine phthalazine aurora kinase inhibitor","volume":"53","author":"Cee","year":"2010","journal-title":"J. Med. Chem."},{"key":"2026090305340405800_cit28","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1021\/jm8005417","article-title":"Discovery of highly\nselective and potent p38 inhibitors based on a phthalazine scaffold","volume":"51","author":"Herberich","year":"2008","journal-title":"J. Med. Chem."},{"key":"2026090305340405800_cit29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bmcl.2012.11.021","article-title":"Novel cinnoline-based\ninhibitors of LRRK2 kinase activity","volume":"23","author":"Garofalo","year":"2013","journal-title":"Bioorg.\nMed. Chem. Lett."},{"key":"2026090305340405800_cit30","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.bmcl.2011.01.033","article-title":"3-amido-4-anilinocinnolines\nas a novel class of CSF-1R inhibitor","volume":"21","author":"Scott","year":"2011","journal-title":"Bioorg.\nMed. Chem. Lett."},{"key":"2026090305340405800_cit31","unstructured":"Geierstanger, B.; Ou, W.; Cellitti, S. E.; Uno, T.; Crossgrove, T.; Chiu, H.-P.; Grunewald, J.; Hao, X.\n          Bio-synthetically generated pyrroline-carboxy-lysine\nand site specific protein modifications via chemical derivatization\nof pyrroline-carboxy-lysine and pyrrolysine residues. WO2010048582A1, 2010."},{"key":"2026090305340405800_cit32","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1016\/j.bmc.2006.06.047","article-title":"Synthesis and SAR of indazole-pyridine\nbased protein kinase B\/Akt inhibitors","volume":"14","author":"Woods","year":"2006","journal-title":"Bioorg.\nMed. Chem."},{"key":"2026090305340405800_cit33","unstructured":"Vandyck, K.; Verschueren, W. G.; Raboisson, P. J.-M. B.\n          Preparation\nof heterobicyclic derivatives end-capped with peptide derivatives\nas HCV replication inhibitors for treating hepatitis C. WO2012013643A1, 2012."},{"key":"2026090305340405800_cit34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1101\/gr.115089.110","article-title":"High-throughput phenotyping using parallel sequencing of RNA interference\ntargets in the African trypanosome","volume":"21","author":"Alsford","year":"2011","journal-title":"Genome Res."},{"key":"2026090305340405800_cit35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0001253","article-title":"A screen against Leishmania intracellular\namastigotes: comparison to a promastigote screen and identification\nof a host cell-specific hit","volume":"5","author":"De Muylder","year":"2011","journal-title":"PLoS Neglected\nTrop. Dis."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.5b00515","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/58\/14\/5522\/67198718\/acs.jmedchem.5b00515.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/58\/14\/5522\/67198718\/acs.jmedchem.5b00515.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T09:34:13Z","timestamp":1788428053000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/58\/14\/5522\/1339173\/Protozoan-Parasite-Growth-Inhibitors-Discovered-by"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,18]]},"references-count":35,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2015,6,18]]},"published-print":{"date-parts":[[2015,7,23]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00515","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,18]]}}}